Clinical trial concern28th November 2012
The latest Access to Medicine Index report has said that few drug companies have robust measures to ensure outsourced clinical trials in developing countries are safe and ethical.
The document reported that most companies were unable to provide any evidence of exerting real influence over the way the trials were conducted by contractors, though it did praise drug manufacturers for making more effort to provide affordable medicines. Published every two years and ranking the world’s 20 biggest drug companies, it showed GlaxoSmithKline remaining at the top of the index, followed by Johnson & Johnson and Sanofi.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.